Contraception
RSSArticles
-
Levonorgestrel Emergency Contraception Works Well — Even if Taken Before Sex
A new study using a mathematical model finds that an oral dose of 1.5 mg levonorgestrel emergency contraceptive (LNG-EC) is safe and largely effective both when taken shortly before sexual intercourse and shortly after — so long as the woman is not ovulating.
-
Women Who Want Immediate Postpartum LARC Face Various Barriers
Long-acting reversible contraception (LARC) barriers include its higher cost and the need for in-clinic/office insertion and removal.
-
Many People Still Report Experiencing Reproductive Counseling Coercion
Subtle and more overt acts of reproductive counseling coercion still occur in the United States, affecting more than two in five women in their lifetime, research shows.
-
Research Shows that Misoprostol Works Well Alone for Medication Abortion
When Americans think of medication abortion, they typically refer to the medication regimen of mifepristone and misoprostol, which together have been shown to be highly effective and safe.
-
Opill’s Access Is Great, But Price Is Too Steep for Youth
As Opill, the first over-the-counter (OTC) oral birth control pill to be approved by the Food and Drug Administration (FDA), makes its way to grocery stores and pharmacies across the country, its usefulness remains a question mark for many young people.
-
Preconception Consult Should Include Advice on Contraception
Separating preconception and contraceptive counseling between OB/GYNs and patients burdens patients and fractures reproductive healthcare. A better solution is to look at pregnancy planning, pregnancy prevention, and risk evaluation holistically.
-
Combined Oral Contraceptives Can Help Some with Premenstrual Dysphoric Disorder
Reproductive health patients often describe having unpleasant symptoms related to their menstrual cycle. Premenstrual syndrome, for example, refers to any mood symptoms in the days or weeks before their period begins.
-
Male Contraceptive Gel Is Most Promising Option in that Arena
Researchers have released positive results from a Phase II study of Nestorone/testosterone (NES/T) transdermal gel, the first male contraception method to progress to Phase II clinical trials.
-
U.S. Supreme Court’s Decision on Emergency Abortions Raises More Questions than Answers
The big question for OB/GYNs, emergency department (ED) physicians, and the reproductive healthcare community is whether the U.S. Supreme Court’s decision on June 27, 2024, in the case of Idaho and Moyle v. United States, will change emergency care for pregnant women in the United States.
-
Study Shows that Family Planning Needs of Hispanics Vary According to Acculturation
New research of Hispanic women surveyed at a public hospital in a New York City suburb shows that a large proportion — nearly three in five — were unaware of the Dobbs Supreme Court decision that overturned Roe v. Wade.